These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37896142)

  • 1. Conceptual Framework of the Design of Pleiotropic Drugs against Alzheimer's Disease.
    Guiselin T; Lecoutey C; Rochais C; Dallemagne P
    Pharmaceutics; 2023 Sep; 15(10):. PubMed ID: 37896142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the discovery of heterocyclic-based drugs against Alzheimer's disease.
    Sánchez JD; Alcántara AR; González JF; Sánchez-Montero JM
    Expert Opin Drug Discov; 2023; 18(12):1413-1428. PubMed ID: 37800875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-Target Drug Candidates for Multifactorial Alzheimer's Disease: AChE and NMDAR as Molecular Targets.
    Uddin MS; Al Mamun A; Kabir MT; Ashraf GM; Bin-Jumah MN; Abdel-Daim MM
    Mol Neurobiol; 2021 Jan; 58(1):281-303. PubMed ID: 32935230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One for All? Hitting Multiple Alzheimer's Disease Targets with One Drug.
    Hughes RE; Nikolic K; Ramsay RR
    Front Neurosci; 2016; 10():177. PubMed ID: 27199640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease.
    Sahoo AK; Dandapat J; Dash UC; Kanhar S
    J Ethnopharmacol; 2018 Apr; 215():42-73. PubMed ID: 29248451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural fingerprinting of pleiotropic flavonoids for multifaceted Alzheimer's disease.
    Punmiya A; Prabhu A
    Neurochem Int; 2023 Feb; 163():105486. PubMed ID: 36641110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Silico Molecular Docking Analysis of Karanjin against Alzheimer's and Parkinson's Diseases as a Potential Natural Lead Molecule for New Drug Design, Development and Therapy.
    Gnanaraj C; Sekar M; Fuloria S; Swain SS; Gan SH; Chidambaram K; Rani NNIM; Balan T; Stephenie S; Lum PT; Jeyabalan S; Begum MY; Chandramohan V; Thangavelu L; Subramaniyan V; Fuloria NK
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-Target Directed Drugs as a Modern Approach for Drug Design Towards Alzheimer's Disease: An Update.
    de Freitas Silva M; Dias KST; Gontijo VS; Ortiz CJC; Viegas C
    Curr Med Chem; 2018; 25(29):3491-3525. PubMed ID: 29332563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of Anti-Alzheimer's Disease Activity of Selected Plant Ingredients.
    Tuzimski T; Petruczynik A
    Molecules; 2022 May; 27(10):. PubMed ID: 35630702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposome based drug delivery as a potential treatment option for Alzheimer's disease.
    Hernandez C; Shukla S
    Neural Regen Res; 2022 Jun; 17(6):1190-1198. PubMed ID: 34782553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AD "Statin": Alzheimer's Disorder is a "Fast" Disease Preventable by Therapeutic Intervention Initiated Even Late in Life and Reversible at the Early Stages.
    Volloch V; Olsen BR; Rits S
    Ann Integr Mol Med; 2020; 2(1):75-89. PubMed ID: 32201863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics of Alzheimer's Disease: Novel Strategies for Drug Utilization and Development.
    Cacabelos R; Naidoo V; Martínez-Iglesias O; Corzo L; Cacabelos N; Pego R; Carril JC
    Methods Mol Biol; 2022; 2547():275-387. PubMed ID: 36068470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postulating the possible cellular signalling mechanisms of antibody drug conjugates in Alzheimer's disease.
    Punyakoti P; Behl T; Sehgal A; Yadav S; Sachdeva M; Anwer MK; Vargas-De-La-Cruz C; Venkatachalam T; Naqvi M; Verma R; Tuli HS
    Cell Signal; 2023 Feb; 102():110539. PubMed ID: 36455831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multitarget Directed Ligand Approaches for Alzheimer's Disease: A Comprehensive Review.
    Ramalakshmi N; R S R; C N N
    Mini Rev Med Chem; 2021; 21(16):2361-2388. PubMed ID: 33820504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapies for sleep disturbances in Alzheimer's disease.
    McCleery J; Cohen DA; Sharpley AL
    Cochrane Database Syst Rev; 2014 Mar; (3):CD009178. PubMed ID: 24659320
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.